Advances in Hematology
Volume 2019, Article ID 4625787, 12 pages
https://doi.org/10.1155/2019/4625787
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France
1Millennium Pharmaceuticals, Inc., A Wholly Owned Subsidiary of Takeda Pharmaceutical Company Limited, 40 Landsdowne Street, Cambridge, MA 02139, USA
2RTI Health Solutions, 200 Park Offices Drive, Research Triangle Park, NC 27709, USA
3RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA 02452, USA
4Department of Haematology, Hôpital Saint-Antoine, Sorbonne University, INSERM UMRs 938, EBMT Paris Study Office, CEREST-TC, Saint-Antoine Hospital, Paris, France
Correspondence should be addressed to Keith L. Davis; gro.itr@sivadlk
Received 6 April 2018; Accepted 16 December 2018; Published 29 January 2019
Academic Editor: Francesco Dazzi
Copyright © 2019 Huamao Mark Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Order Reprints
- Quantity0
- Order Charges0
- Total$0